Please join us and Dr. Arif Kamal, Duke University for the CT Oncology Association Virtual Webinar on Tuesday January 18, 2022
Better Outcomes Through Shared Decision-making
CONNECTICUT ONCOLOGY ASSOCIATION MEETING
Meeting Date: Monday Jan 31 (Moved from the 18th) 2022 Time: Virtual Meeting 4:30 p.m. to 5:30 p.m. (moved from 5:30 on the 18th)
Location: Webinar invitation and directions for connection will be emailed to all registered participants 2 to 3 days before the meeting
Topic Better Outcomes Through Shared Decision-making
The presentation, as are all our CtOA programs, is available to all physicians, clinical and administrative staff of our CT practices at no charge. Please register as soon as possible to secure your spots. The sign-in link will be sent to all registrants a few days before the program.
This program is being presented by Arif Kamal, MD, MBA, MHS, FACP, FAAHPM, FASCO. Dr. Kamal is an Associate Professor of Medicine, Business Administration, and Population Health Sciences in the Division of Medical Oncology and Section of Palliative Care at Duke University. As a fellowship-trained palliative medicine physician and medical oncologist, Dr. Kamal studies the link between deliver of high-quality palliative care and improved patient, caregiver, and health systems outcomes.
You may register for this event on the CtOA website www.ctoncology.com , or at www.abbvie.meintl.com/ORB03-OU01-22 . You may also register by replying to me at dawnho@aol.com, or to Stacy Sullivan at 860-414-9379 or stacy.sullivan@abbvie.com.
The Connecticut Oncology Association is pleased to partner with its Charter Oak corporate members to offer selected webinar presentations to CtOA members in addition to our regular meetings. This program is presented on behalf of Abbvie, a Charter Oak member of the Connecticut Oncology Association.
This unique Charter Oak Partner presentation are limited only to all CtOA oncology practice members: the physicians, admin and staff of oncology and guest medical groups, but not Corporate Partners. We appreciate your understanding of this select audience parameter. General CT Oncology Association meetings/webinars will remain open to all medical and corporate partner members.
We are developing other exciting programming for 2022 and hope to resume in person meetings in the late spring.
Stay healthy, and we will see each other soon!
We will also be discussing plans for the Connecticut Oncology Association projects and meetings in 2022, and look forward to participation from practice physicians, administration and nurses. All are encouraged to attend. We also extend a warm welcome to any Residents or Fellows who wish to join us.
Please join the Connecticut Oncology Association in thanking our 2021 and emerging 2022 Charter Oak Partners to Date for helping us to bring informative programs to our members: Abbvie, AstraZeneca, Bristol Meyer Squibb, Eisai, Genentech, Merck, Oncopeptides, Sanofi, Seattle Genetics and Takeda Millenium. 2022 Corporate Partnership Applications are Now Available. Please note that each Charter Oak Partner has useful product and contact information on their pages at the www.ctoncology.com website, for your convenience.
We would also like to thank our other 2021 Nutmeg level corporate partners: Astellas, Exelixis, Johnson & Johnson, Novartis, Pfizer and Taiho Oncology. We look forward to welcoming these partners and others in 2022.
Please Complete & email the Registration Information Below by Monday January 17 at noon.
I will be attending the CtOA Webinar, Tuesday Jan. 18, 2022 at 5:30 - 7 pm Yes____ No___
Please register at www.ctoncology.com, Or email to dawnho@aol.com
It is important to provide contact phone and email information, in order to send you the link and sign-in information a few days before the event..
Name: ____________ Affiliation:______________________________
Contact Phone #:_______________ Contact Email: ________________________ ______
Staff and Physicians for Connecticut Practices, Physicians and staff No Charge
Corporate Affiliate Members no charge for this webinar, but may be subject to capacity limits
Thanks, Dawn
Dawn Holcombe FACMPE MBA ACHE
Executive Director, Connecticut Oncology Association
33 Woodmar Circle
cell/main 860-305-4510,
dawnho@aol.com (main)
www.ctoncology.com